Home » Authors » Glen Harris

Articles by Glen Harris

Tobira Ramps Up HIV Pipeline With 2 Candidates And $31M

Aug. 3, 2007

Tobira Ramps Up HIV Pipeline With 2 Candidates And $31M

Aug. 3, 2007

Coley Stock Plunges As Pfizer Abandons NSCLC Program

June 21, 2007

Shares of Coley Pharmaceutical Group Inc. sank nearly 60 percent Wednesday on news that partner Pfizer Inc. has walked away from the investigation lung cancer drug PF-3512676, shelving two Phase III and two Phase II trials. (BioWorld Today)

Coley Stock Plunges As Pfizer Abandons NSCLC Program

June 21, 2007

Shares of Coley Pharmaceutical Group Inc. sank nearly 60 percent Wednesday on news that partner Pfizer Inc. has walked away from the investigation lung cancer drug PF-3512676, shelving two Phase III and two Phase II trials. (BioWorld Today)

Memory Replenishes Coffers And Alters Deals with Roche

June 20, 2007

Memory Replenishes Coffers And Alters Deals with Roche

June 20, 2007

Nektar Cuts Spending By $65M In Management Reorganization

May 25, 2007

Nektar Cuts Spending By $65M In Management Reorganization

May 25, 2007

Staying Clean, Coming Clean Keys To Avoiding Legal Woes

May 9, 2007

Staying Clean, Coming Clean Keys To Avoiding Legal Woes

May 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 3, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.